Efficacy of polyglucosamine for weight loss-confirmed in a randomized double-blind, placebo-controlled clinical investigation

BMC Obesity

Volumn 2, Issue 1, 2015, Pages

  Pokhis, Karina ^a   Bitterlich, Norman ^b   Cornelli, Umberto ^c   Cassano, Giuseppina ^d  

^a Salztal Klinik GmbH   (Germany)

^b Medizin Service Biometrie   (Germany)

^c LOYOLA UNIVERSITY CHICAGO   (United States)

^d MAP center   (Italy)

Author keywords

Body weight; Caloric restriction; Obesity; Overweight; Physical activity; Polyglucosamine; Weight loss

Indexed keywords

ANTIOBESITY AGENT; ASCORBIC ACID; CHITOSAN; LOW MOLECULAR WEIGHT CHITOSAN; PLACEBO; POLYGLUCOSAMINE; TARTARIC ACID; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BODY MASS; BODY WEIGHT; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; LIPID DIET; LOW CALORY DIET; MAJOR CLINICAL STUDY; MALE; MAXIMUM BINDING CAPACITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WAIST CIRCUMFERENCE; WEIGHT REDUCTION;

EID: 84969298988     PISSN: None     EISSN: 20529538     Source Type: Journal    
DOI: 10.1186/s40608-015-0053-5     Document Type: Article

References (17)

1. World Health Organisation; Media centre; Obesity and overweight; Fact sheet No311 http://www.who.int/mediacentre/factsheets/fs311/en/
2. Astrup A, Ryan L, Grunwald GK, et al. The role of low-fat diets in body weight control: a preliminary meta-analysis of ad libitum dietary intervention studies. Int J Obes. 2000;24:1545-52.
3. Evidenzbasierte Leitlinie Prävention und Therapie der Adipositas, Version 2007, Herausgerber DAG, DDG, DGE, DGEM,; H. Hauner et al. www.adipositasgesellschaft. de/fileadmin/PDF/Leitlinien/Adipositas-Leitlinie-2007.pdf
4. European Medicines Agency; Press release 22/01/2010; European Medicines Agency recommends suspension of marketing authorisation for sibutramine; http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2010/01/news_detail_000985.jsp
5. European Medicines Agency; Press release 23/10/2008; The European Medicines Agency recommends suspension of the marketing authorisation of Acomplia; http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2009/11/WC500014774.pdf
6. Bondiolotti G, Bareggi SR, Frega NG, Strabioli S, Cornelli U. Activity of different polyglucosamine, L112 and FF45, on body weight in male rats. Eur J Pharmacol. 2007;567:155-8.
7. Bondiolotti G, Cornelli U, Strabbioli RS, Frega NG, Cornelli M. Effect of a polyglucosamine on the body weight of male rats: Mechanisms of action. Food Chem. 2011;124:978-82.
8. Popitt SD, Keogh GF, Prentice AM, et al. Long-term effects of ad libitum low-fat, high-carbohydrate diets on body weight and serum lipids in overweight subjects with metabolic syndrome. Am J Clin Nutr. 2002;75:11-20.
9. Toubro S, Astrup A. Randomised comparisons of diets for maintaining obese subjects' weight after major weight loss: ad lib, low fat, high carbohydrate diet vs fixed energy intake. BMJ. 1997;314:29-34.
10. Ni Mhurchu C, Poppit SD, McGill AT, et al. The effect of t e dietary supplement, Chitosan, on body weight: a randomised controlled trial in 250 overweight and obese adults. Int J Obes. 2004;28:1149-56.
11. Jull AB, Ni Mhurchu C, Bennet DA, Dunshea-Mooij CAE, Rodgers A Chitosan for overweight or obesity. Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD003892. doi:10.1002/14651858.CD003892.pub3.
12. Gades MD, Stern JS. Chitosan supplementation and fecal fat excretion in men. Obes Res. 2003;11:683-8.
13. Chiang MT, Yao HT, Chen HC. Effects of dietary chitosans with different viscosity on plasma lipids and lipids peroxidation in rats fed on a diet enriched with cholesterol. Biosci Biotech Biochem. 2000;64:965-71.
14. Kanauki O, Deichi K, Imasato Y, Kobaiashi E. Increasing effect of a chitosan and ascorbic acid mixture on fecal dietary fat excretion. Biosci Biotech Biochem. 1994;58:1617-20.
15. Kaats GR, Michalek JE, Preuss HG. Evaluation efficacy of a chitosan product using a double-blinded, placebo controlled protocol. J Am Coll Nutr. 2006;25:369-94.
16. Walsh AM, Sweeney T, Bahar B, O'Doherty JV. Multi-functional role of chitosan as a potential protective agents against the obesity. PLOS one 2013;8:e53828. doi:10.317/journal.pone.00553828.
17. Cornelli U, Belcaro G, Cesarone MR, Cornelli M. Use of polyglucosamine and physical activity and dyslipidemia in moderately overweight subjects. Minerva Cardioangiol. 2008;56:71-8.